Skip to content
Medinova Diagnostic Services logo

Medinova Diagnostic Services

526301 BSE
Price unavailable
View as Markdown
MCP
Close 24 Nov 2025 ₹43.45 −0.67 −1.52% since 6 Nov 2025
Start ₹44.12

Key Insights

No strengths listed

Weaknesses

1
  • The company has delivered a poor sales growth of 5.66% over past five years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bullish3610
OscillatorsBullish162
Moving AveragesStrong Bullish208

Key readings

RSI (14)
56.75
Neutral
MACD (12,26,9)
0.90
Bullish
SMA (50)
41.26
Bullish
SMA (200)
39.92
Bullish

As of , the latest day with price data, so these readings are not current.

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2025; 1Y: fiscal year to Mar 2025 against Mar 2024.

Revenue

Revenue growth by window
10Y+3.43%
5Y+5.66%
3Y−9.42%
1Y−3.54%

Net profit

Net profit growth by window
10YTurned to profit
5YTurned to profit
3Y−7.23%
1Y−5.00%

Operating cash flow

Operating cash flow growth by window
10Y—
5Y+15.24%
3Y+23.13%
1Y−5.62%

10Y: The statements do not go back far enough for this window.

Operating margin· change in pp

Operating margin growth by window
10Y+78.05 pp
5Y+15.08 pp
3Y+2.78 pp
1Y+3.36 pp

Trailing twelve months: The latest quarterly results are more than a year old.

Revenue by year

Revenue by year, ₹ crore
Mar 2016₹7.47 Cr
Mar 2017₹7.79 Cr
Mar 2018₹8.67 Cr
Mar 2019₹8.97 Cr
Mar 2020₹7.45 Cr
Mar 2021₹12.74 Cr
Mar 2022₹13.20 Cr
Mar 2023₹9.99 Cr
Mar 2024₹10.17 Cr
Mar 2025₹9.81 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2016−₹2.07 Cr
Mar 2017−₹1.74 Cr
Mar 2018−₹0.45 Cr
Mar 2019₹0.82 Cr
Mar 2020−₹0.23 Cr
Mar 2021₹1.90 Cr
Mar 2022₹2.38 Cr
Mar 2023₹1.67 Cr
Mar 2024₹2.00 Cr
Mar 2025₹1.90 Cr

Quarterly Results

₹ Cr

Results for the period ended Dec 2025 were due by 14 Feb 2026 and are not in this table yet.

526301 quarterly results, ₹ crore
Particulars Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Sales
2.56
2.22
2.75
2.42
2.87
2.39
2.49
2.49
2.56
2.25
2.51
2.72
2.5
Expenses
1.93
1.73
1.83
1.89
1.97
1.8
1.74
1.8
1.76
1.59
1.66
1.67
1.57
Operating Profit
0.63
0.49
0.92
0.53
0.9
0.59
0.75
0.69
0.8
0.66
0.85
1.05
0.93
OPM %
24.61%
22.07%
33.45%
21.9%
31.36%
24.69%
30.12%
27.71%
31.25%
29.33%
33.86%
38.6%
37.2%
Other Income
0.03
0.01
0.16
0.02
0.02
0.03
0.13
0.02
0.03
0.03
0.07
0.06
0.03
Interest
0.16
0.14
0.14
0.14
0.14
0.14
0.14
0.12
0.13
0.13
0.12
0.12
0.11
Depreciation
0.1
0.08
0.04
0.03
0.03
0.03
0.03
0.03
0.04
0.04
0.04
0.04
0.03
PBT
0.4
0.28
0.9
0.38
0.75
0.45
0.71
0.56
0.66
0.52
0.76
0.95
0.82
Tax %
10%
17.86%
14.44%
13.16%
10.67%
11.11%
15.49%
23.21%
25.76%
26.92%
22.37%
31.58%
35.37%
Net Profit
0.36
0.23
0.77
0.33
0.66
0.4
0.6
0.42
0.5
0.38
0.6
0.66
0.51
EPS (₹)
0.36
0.23
0.77
0.33
0.66
0.4
0.6
0.42
0.5
0.38
0.6
0.66
0.51

Profit & Loss

₹ Cr
526301 profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales
7
7.47
7.79
8.67
8.97
7.45
12.74
13.2
9.99
10.17
9.81
9.98
Expenses
10.28
7.49
7.68
7.94
7.64
6.25
9.74
9.45
7.34
7.34
6.75
6.49
Operating Profit
−3.28
−0.02
0.11
0.73
1.33
1.2
3
3.75
2.65
2.83
3.06
3.49
OPM %
−46.86%
−0.27%
1.41%
8.42%
14.83%
16.11%
23.55%
28.41%
26.53%
27.83%
31.19%
34.97%
Other Income
0.33
0.17
1.77
1.48
1.7
0.07
0.14
0.15
0.23
0.2
0.12
0.19
Interest
0.23
0.52
1.06
0.84
0.66
0.59
0.46
0.56
0.65
0.62
0.54
0.48
Depreciation
1.03
1.92
2.66
1.88
1.29
0.95
0.72
0.55
0.33
0.13
0.14
0.15
PBT
−4.21
−2.29
−1.84
−0.51
1.08
−0.27
1.96
2.79
1.9
2.28
2.5
3.05
Tax %
−14.73%
−9.61%
−5.43%
−11.76%
25%
−18.52%
3.06%
15.05%
12.11%
12.28%
24%
—
Net Profit
−3.59
−2.07
−1.74
−0.45
0.82
−0.23
1.9
2.38
1.67
2
1.9
2.15
EPS (₹)
−3.78
−2
−1.74
−0.45
0.82
−0.26
2.02
2.27
1.67
2
1.9
2.15
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
526301 balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
9.46
9.46
9.96
9.96
9.96
9.96
9.96
9.96
9.96
9.96
9.96
9.96
Reserves
−16.24
−18.14
−19.52
−19.66
−18.87
−19.13
−17.15
−16.77
−15.09
−13.08
−11.2
−10.04
Borrowings
1.89
8.9
8.45
7.26
6.43
5.64
4.47
6.38
5.75
5
5
4
Other Liabilities
15.27
12.59
9.7
8.51
7.25
7.59
7.1
4.87
3.86
3.5
3.17
3.7
Total Liabilities
10.38
12.81
8.59
6.07
4.77
4.06
4.38
4.44
4.48
5.38
6.93
7.62
Fixed Assets
6.54
9.24
6.89
4.48
3.34
2.4
1.87
1.49
1.55
1.64
1.94
1.88
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
1.51
2.28
Other Assets
3.84
3.57
1.7
1.59
1.43
1.66
2.51
2.95
2.93
3.74
3.48
3.46
Total Assets
10.38
12.81
8.59
6.07
4.77
4.06
4.38
4.44
4.48
5.38
6.93
7.62

Cash Flow

₹ Cr
526301 cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating
—
−0.62
0.08
1.16
1.3
1.24
1.69
1.35
1.42
2.67
2.52
Investing
—
−4.65
−0.11
0.37
−0.15
−0.16
−0.06
−1.84
−0.34
−0.21
−1.9
Financing
—
5.33
−0.01
−1.5
−1.2
−1.07
−1.37
0.31
−0.85
−1.32
−0.63
Net Cash Flow
—
0.06
−0.04
0.04
−0.06
0.01
0.25
−0.17
0.23
1.14
−0.01
Free Cash Flow
—
−5.27
−0.03
1.53
1.15
1.23
1.5
1.19
1.03
2.46
2.04
CFO/OP
—
3,100
73
159
123
106
56
49
57
98
93

Ratios

526301 financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days
37.54
22.48
14.53
8.84
19.12
17.15
23.78
14.38
25.58
15.43
20.46
Inventory Days
86.45
58.99
32.3
—
—
—
—
—
—
—
—
Days Payable
3,463
1,534
1,353
—
—
—
—
—
—
—
—
Cash Conversion Cycle
−3,339
−1,452
−1,307
8.84
19.12
17.15
23.78
14.38
25.58
15.43
20.46
Working Capital Days
−623
−548
−455
−371
−341
−406
−199
−123
−97.92
−92.95
−81.48
ROCE %
—
—
—
—
—
—
—
—
2684.21%
232%
108.87%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Medinova Diagnostic Services insights

29 extracted metrics across FY15–FY26.

Shareholding Pattern

Latest filing: Sep 2025

As of Sep 2025

  • Promoters 62.14%
  • Public 37.87%

Pledge data not available

Change vs previous quarter

Documents

Frequently Asked Questions about Medinova Diagnostic Services

What does Medinova Diagnostic Services Ltd do?
Incorporated in 1985, Medinova Diagnostic Services Ltd is in the business of providing diagnostic services.
Where is Medinova Diagnostic Services Ltd (MEDINOV) listed?
Medinova Diagnostic Services Ltd trades under code 526301 on the BSE.
Which sector does Medinova Diagnostic Services Ltd belong to?
Medinova Diagnostic Services Ltd is classified under the Healthcare sector, in the Healthcare Services industry.

Company Information

Incorporated in 1985, Medinova Diagnostic Services Ltd is in the business of providing diagnostic services.

Website medinovaindia.com
Listed 16 Jan 2013
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/526301.md for Medinova Diagnostic Services Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month